Modulation of β-catenin/TCF-activated transcription

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7531320
APP PUB NO 20050059628A1
SERIAL NO

10928626

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides compounds and methods for modulating transcription activated by β-catenin/TCF, such as the selective inhibition of genes targeted by the Wnt/β-catenin pathway.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHOONGWAE PHARMA CORPORATIONSEOUL 156-757

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ha, JongRyul Suwon, KR 1 24
Hojjati-Emami, Katayoon Seattle, US 1 24
Kahn, Michael Kirkland, US 94 1747
Kim, DaeHoon Suwon, KR 23 191
Oh, SeWoong Suwon, KR 5 29

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation